Speaker illustration

Doctor Shakhnoza Mukhtarova

Tashkent Pediatric Medical Institute, Tashkent (Uzbekistan)

Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.

Event: Heart Failure 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 5

Thumbnail

Risk stratification of adverse events in patients with coronary artery disease with type 2 diabetes with preserved ejection fraction

Event: Heart Failure 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 5

Thumbnail